Filing Flows › Elevance Health (ELV) › Q2 2026
Elevance Health (ELV) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 15, 2026
Elevance Health (ELV) reported revenue of $50.5B for the second quarter 2026 (Q2 2026), +1% from a year earlier and +0.6% from the quarter before. Operating margin was 3.5%, net earnings $1.5B (2.9% of revenue).
Elevance Health, Q2 2026: revenue $50.5B (+1% year over year), operating margin 3.5%, net earnings $1.5B, operating cash flow $1.9B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50.5B | +0.6% | +1% |
| Operating profit | $1.8B | -15% | -27% |
| Net earnings | $1.5B | -17% | -17% |
| Operating cash flow | $1.9B | -56% | -7% |
| Free cash flow | $1.6B | -60% | -9% |
What changed
Revenue was $50.5B in Q2 2026, up 1% year over year and up 1% from the previous quarter.
Operating profit was $1.8B, a 3.5% margin (down 1.4 points year over year). Operating profit fell $0.66B even though revenue rose $0.70B versus Q2 2025, so costs grew faster than sales. Total costs grew 3% against revenue growth of 1%. The fastest-growing cost line was SG&A (+11%). Net earnings were $1.5B, down 16% year over year. The effective tax rate was 24.9%.
Operating cash flow was $1.9B (down 7% year over year), 132% of net earnings. Non-cash charges added back $0.37B of depreciation and amortization and $0.07B of share-based compensation. Capital expenditures of $0.29B left free cash flow of $1.6B.
Questions
What was Elevance Health's revenue in the second quarter 2026?
Elevance Health (ELV) reported revenue of $50.5B for the second quarter 2026 (Q2 2026), +1% from a year earlier and +0.6% from the quarter before.
Was Elevance Health profitable in the second quarter 2026?
Operating profit was $1.8B (3.5% of revenue) and net earnings $1.5B.
Source: Elevance Health 10-Q on SEC EDGAR.